Florian Krammer
Cited by
Cited by
Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals
A Grifoni, D Weiskopf, SI Ramirez, J Mateus, JM Dan, CR Moderbacher, ...
Cell 181 (7), 1489-1501. e15, 2020
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
JM Dan, J Mateus, Y Kato, KM Hastie, ED Yu, CE Faliti, A Grifoni, ...
Science 371 (6529), eabf4063, 2021
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ...
Science 370 (6515), eabd4570, 2020
SARS-CoV-2 vaccines in development
F Krammer
Nature 586 (7830), 516-527, 2020
A serological assay to detect SARS-CoV-2 seroconversion in humans
F Amanat, D Stadlbauer, S Strohmeier, THO Nguyen, V Chromikova, ...
Nature medicine 26 (7), 1033-1036, 2020
Immunology of COVID-19: current state of the science
N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ...
Immunity 52 (6), 910-941, 2020
SARS-CoV-2 vaccines: status report
F Amanat, F Krammer
Immunity 52 (4), 583-589, 2020
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
A Wajnberg, F Amanat, A Firpo, DR Altman, MJ Bailey, M Mansour, ...
Science 370 (6521), 1227-1230, 2020
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
M Imai, K Iwatsuki-Horimoto, M Hatta, S Loeber, PJ Halfmann, ...
Proceedings of the National Academy of Sciences 117 (28), 16587-16595, 2020
Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine
F Krammer, K Srivastava, H Alshammary, AA Amoako, MH Awawda, ...
New England Journal of Medicine 384 (14), 1372-1374, 2021
SARS‐CoV‐2 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup
D Stadlbauer, F Amanat, V Chromikova, K Jiang, S Strohmeier, ...
Current protocols in microbiology 57 (1), e100, 2020
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
JS Turner, JA O’Halloran, E Kalaidina, W Kim, AJ Schmitz, JQ Zhou, T Lei, ...
Nature 596 (7870), 109-113, 2021
Advances in the development of influenza virus vaccines
F Krammer, P Palese
Nature reviews Drug discovery 14 (3), 167-182, 2015
The human antibody response to influenza A virus infection and vaccination
F Krammer
Nature Reviews Immunology 19 (6), 383-397, 2019
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
SV Bardina, P Bunduc, S Tripathi, J Duehr, JJ Frere, JA Brown, ...
Science 356 (6334), 175-180, 2017
Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C)
CN Gruber, RS Patel, R Trachtman, L Lepow, F Amanat, F Krammer, ...
Cell 183 (4), 982-995. e14, 2020
Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
STH Liu, HM Lin, I Baine, A Wajnberg, JP Gumprecht, F Rahman, ...
Nature medicine 26 (11), 1708-1713, 2020
The first 12 months of COVID-19: a timeline of immunological insights
T Carvalho, F Krammer, A Iwasaki
Nature Reviews Immunology 21 (4), 245-256, 2021
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
JM Carreņo, H Alshammary, J Tcheou, G Singh, AJ Raskin, H Kawabata, ...
Nature 602 (7898), 682-688, 2022
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
N Pardi, MJ Hogan, MS Naradikian, K Parkhouse, DW Cain, L Jones, ...
Journal of Experimental Medicine 215 (6), 1571-1588, 2018
The system can't perform the operation now. Try again later.
Articles 1–20